Background Bacterial co-pathogens are commonly identified in viral respiratory infections
and are important causes of morbidity and mortality. The prevalence of bacterial infection in …

Background The proportion of patients infected with SARS-CoV-2 that are prescribed
antibiotics is uncertain, and may contribute to patient harm and global antibiotic resistance. …

Bacteria that cause infections in humans can develop or acquire resistance to antibiotics
commonly used against them 1, 2. Antimicrobial resistance (in bacteria and other microbes) …

Background COVID-19 and antimicrobial resistance (AMR) are two intersecting global public
health crises. Objective We aimed to describe the impact of the COVID-19 pandemic on …

Background. Reported allergy to beta-lactam antibiotics is common and often leads to
unnecessary avoidance in patients who could tolerate these antibiotics. We prospectively …

10.7554/eLife.39435.001 Antibiotic use is a primary driver of antibiotic resistance. However,
antibiotic use can be distributed in different ways in a population, and the association …

Background The prevalence of bacterial infection in patients with COVID-19 is low, however,
empiric antibiotic use is high. Risk stratification may be needed to minimize unnecessary …

Background: Sex differences in the use and outcomes of implantable cardioverter-defibrillators
(ICDs) have not been fully studied. Objective: To examine potential sex differences in ICD …

Bloodstream infections (BSIs) represent a substantial mortality risk, yet most studies are limited
to select pathogens or populations. The aim of this study was to describe the population-…

Surveillance of drug-resistant bacteria is essential for healthcare providers to deliver
effective empirical antibiotic therapy. However, traditional molecular epidemiology does not …